Project Details
Description
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Crinecerfont (NBI-74788) in Pediatric Subjects with Classic Congenital Adrenal Hyperplasia, Followed by Open-Label Treatment
| Status | Active |
|---|---|
| Effective start/end date | 2/12/21 → 2/28/26 |
Funding
- NEUROCRINE BIOSCIENCES, INC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.